GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Naturewise Biotech & Medicals Corp (ROCO:4732) » Definitions » ROC (Joel Greenblatt) %

Naturewise Biotech & Medicals (ROCO:4732) ROC (Joel Greenblatt) % : 22.01% (As of Dec. 2023)


View and export this data going back to 2007. Start your Free Trial

What is Naturewise Biotech & Medicals ROC (Joel Greenblatt) %?

Joel Greenblatt defined Return on Capital differently in his book The Little Book That Still Beats the Market (Little Books. Big Profits). He defines ROC (Joel Greenblatt) % as EBIT divided by the total of Property, Plant and Equipment and net working capital. Naturewise Biotech & Medicals's annualized ROC (Joel Greenblatt) % for the quarter that ended in Dec. 2023 was 22.01%.

The historical rank and industry rank for Naturewise Biotech & Medicals's ROC (Joel Greenblatt) % or its related term are showing as below:

ROCO:4732' s ROC (Joel Greenblatt) % Range Over the Past 10 Years
Min: -196.14   Med: -16.39   Max: 141.13
Current: 16.66

During the past 13 years, Naturewise Biotech & Medicals's highest ROC (Joel Greenblatt) % was 141.13%. The lowest was -196.14%. And the median was -16.39%.

ROCO:4732's ROC (Joel Greenblatt) % is ranked better than
88.21% of 1459 companies
in the Biotechnology industry
Industry Median: -333.95 vs ROCO:4732: 16.66

Naturewise Biotech & Medicals's 5-Year average Growth Rate of ROC (Joel Greenblatt) % was 0.00% per year.


Naturewise Biotech & Medicals ROC (Joel Greenblatt) % Historical Data

The historical data trend for Naturewise Biotech & Medicals's ROC (Joel Greenblatt) % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Naturewise Biotech & Medicals ROC (Joel Greenblatt) % Chart

Naturewise Biotech & Medicals Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
ROC (Joel Greenblatt) %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 95.59 141.13 70.84 53.50 13.24

Naturewise Biotech & Medicals Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
ROC (Joel Greenblatt) % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 196.60 88.61 57.30 15.28 22.01

Competitive Comparison of Naturewise Biotech & Medicals's ROC (Joel Greenblatt) %

For the Biotechnology subindustry, Naturewise Biotech & Medicals's ROC (Joel Greenblatt) %, along with its competitors' market caps and ROC (Joel Greenblatt) % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Naturewise Biotech & Medicals's ROC (Joel Greenblatt) % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Naturewise Biotech & Medicals's ROC (Joel Greenblatt) % distribution charts can be found below:

* The bar in red indicates where Naturewise Biotech & Medicals's ROC (Joel Greenblatt) % falls into.



Naturewise Biotech & Medicals ROC (Joel Greenblatt) % Calculation

Joel Greenblatt defined Return on Capital differently in his book The Little Book That Still Beats the Market (Little Books. Big Profits) . He defines Return on Capital as follows:

ROC (Joel Greenblatt) %=EBIT/Average of (Net fixed Assets + Net Working Capital)

EBIT stands for Earnings Before Interest and Taxes.

Fixed Assets are also known as non-current assets. They include the Property, Plant and Equipment that the firm needs in its operation.

GuruFocus calculates net working capital as: (Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Deferred Revenue + Other Current Liabilities). We're trying to account for OPERATING assets and liabilities (part of daily business) when calculating working capital. Cash and marketable securities are considered NON-OPERATING assets and are not included in calculation. We will also back out all interest bearing debt, short term debt and the portion of long term debt that is due in the current period from the current liabilities. This debt will be considered when computing cost of capital and it would be inappropriate to count it twice.

Working Capital(Q: Jun. 2023 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(19.768 + 48.128 + 5.652) - (42.217 + 0 + 7.228)
=24.103

Working Capital(Q: Dec. 2023 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(31.93 + 82.5 + 14.073) - (39.786 + 0 + 7.086)
=81.631

When net working capital is negative, 0 is used.

So ROC (Joel Greenblatt) % of Naturewise Biotech & Medicals for the quarter that ended in Dec. 2023 can be restated as:

ROC (Joel Greenblatt) %(Q: Dec. 2023 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: Jun. 2023  Q: Dec. 2023
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=13.122/( ( (4.867 + max(24.103, 0)) + (8.62 + max(81.631, 0)) )/ 2 )
=13.122/( ( 28.97 + 90.251 )/ 2 )
=13.122/59.6105
=22.01 %

Note: The EBIT data used here is two times the semi-annual (Dec. 2023) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Naturewise Biotech & Medicals  (ROCO:4732) ROC (Joel Greenblatt) % Explanation

The way Joel Greenblatt defines Return on Capital is a more accurate measure of how efficiently the company generates returns onthe capital actually invested in the business. EBIT is used instead of net income because the tax and interest payment may be affected by factors other than the core business operation. Intangible assets are not included in the calculation because they don't need to be replaced.

Joel Greenblatt uses his definition of Return on Capital and Earnings Yield (Joel Greenblatt) % to rank companies.


Naturewise Biotech & Medicals ROC (Joel Greenblatt) % Related Terms

Thank you for viewing the detailed overview of Naturewise Biotech & Medicals's ROC (Joel Greenblatt) % provided by GuruFocus.com. Please click on the following links to see related term pages.


Naturewise Biotech & Medicals (ROCO:4732) Business Description

Traded in Other Exchanges
N/A
Address
No. 36, Bade Road, 6th Floor, Section 3, Taipei, TWN, 105
Naturewise Biotech & Medicals Corp is a Taiwan-based drug development company that focuses on botanical drug and small molecule therapies. Its products include NBM-BMX Oral Softgel Capsule, Lipocol Forte Capsule, and PPLs Taiwan Green Propolis.

Naturewise Biotech & Medicals (ROCO:4732) Headlines

No Headlines